Merck is up 51% from its yearly low. The large cap drug sector after underperforming for many years is attracting buyers now.
Major Drug firms
ABBI,Abraxis Bioscience Inc
ABT,Abbott Laboratories
AOB,American Oriental Bioengineering Inc
AZN,Astrazeneca Plc
BMY,Bristol-Myers Squibb Co
GSK,Glaxosmithkline Plc Adr
JNJ,Johnson & Johnson
KAL,Callisto Pharmaceuticals Inc
KERX,Keryx Biopharmaceuticals
LLY,Eli Lilly & Company
MRK,Merck & Co
NVS,Novartis Ag Ads
PFE,Pfizer Inc
RIGL,Rigel Pharmaceuticals Inc
SGP,Schering-Plough Corp
SPPI,Spectrum Pharm Inc
WYE,Wyeth
No comments:
Post a Comment